Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.Ottaiano A, Scala S, Normanno N, Botti G, Tatangelo F, Di Mauro A, Capozzi M, Facchini S, Tafuto S, Nasti G.Appl Immunohistochem Mol Morphol. 2020 Nov/Dec;28(10):755-760. doi: 10.1097/PAI.0000000000000828.PMID: 31985548
Study of Ras Mutations’ Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.Ottaiano A, Normanno N, Facchini S, Cassata A, Nappi A, Romano C, Silvestro L, De Stefano A, Rachiglio AM, Roma C, Maiello MR, Scala S, Delrio P, Tatangelo F, Di Mauro A, Botti G, Avallone A, Nasti G.Cancers (Basel). 2020 Jul 16;12(7):E1919. doi: 10.3390/cancers12071919.PMID: […]
Multiplex immunohistochemistry assay to evaluate the melanoma tumor microenvironment.Scognamiglio G, Capone M, Mallardo D, Botti G, Ascierto PA, Madonna G.Methods Enzymol. 2020;635:21-31. doi: 10.1016/bs.mie.2019.07.045. Epub 2019 Aug 22.PMID: 32122547
Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma.Granata V, Fusco R, Venanzio Setola S, Sandomenico F, Luisa Barretta M, Belli A, Palaia R, Tatangelo F, Grassi R, Izzo F, Petrillo A.Radiol Oncol. 2020 May 28;54(2):149-158. doi: 10.2478/raon-2020-0029.PMID: 32463393
Integrated Analysis to Study the Relationship between Tumor-Associated Selenoproteins: Focus on Prostate Cancer.Capone F, Polo A, Sorice A, Budillon A, Costantini S.Int J Mol Sci. 2020 Sep 13;21(18):6694. doi: 10.3390/ijms21186694.PMID: 32933107